<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5748641</article-id><article-id pub-id-type="doi">10.3390/ph10040084</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-10-00084</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acorenone B: AChE and BChE Inhibitor as a Major Compound of the Essential Oil Distilled from the Ecuadorian Species <italic>Niphogeton dissecta</italic> (Benth.) J.F. Macbr</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Calva</surname><given-names>James</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-10-00084">1</xref><xref rid="c1-pharmaceuticals-10-00084" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Bec</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="af2-pharmaceuticals-10-00084">2</xref><xref ref-type="aff" rid="af3-pharmaceuticals-10-00084">3</xref><xref ref-type="aff" rid="af4-pharmaceuticals-10-00084">4</xref></contrib><contrib contrib-type="author"><name><surname>Gilardoni</surname><given-names>Gianluca</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-10-00084">1</xref></contrib><contrib contrib-type="author"><name><surname>Larroque</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="af2-pharmaceuticals-10-00084">2</xref><xref ref-type="aff" rid="af3-pharmaceuticals-10-00084">3</xref><xref ref-type="aff" rid="af4-pharmaceuticals-10-00084">4</xref></contrib><contrib contrib-type="author"><name><surname>Cartuche</surname><given-names>Luis</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-10-00084">1</xref></contrib><contrib contrib-type="author"><name><surname>Bicchi</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="af5-pharmaceuticals-10-00084">5</xref></contrib><contrib contrib-type="author"><name><surname>Montesinos</surname><given-names>Jos&#x000e9; Vinicio</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-10-00084">1</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-10-00084"><label>1</label>Department of Chemistry and Exact Sciences, Private Technical University of Loja (UTPL), Calle Marcelino Champagnat s/n, 1101608 Loja, Ecuador; <email>gianluca.gilardoni@gmail.com</email> (G.G.); <email>lecartuche@utpl.edu.ec</email> (L.C.); <email>jvmontesinos@utpl.edu.ec</email> (J.V.M.)</aff><aff id="af2-pharmaceuticals-10-00084"><label>2</label>IRCM, Cancer Research Institute of Montpellier, INSERM, U1194, 34298 Montpellier, France; <email>nicole.bec@inserm.fr</email> (N.B.); <email>christian.larroque@inserm.fr</email> (C.L.)</aff><aff id="af3-pharmaceuticals-10-00084"><label>3</label>Montpellier Regional Cancer Institute, 34298 Montpellier, France</aff><aff id="af4-pharmaceuticals-10-00084"><label>4</label>Institut de Recherche en Canc&#x000e9;rologie de Montpellier, INSERM, U1194, University of Montpellier, 34298 Montpellier, France</aff><aff id="af5-pharmaceuticals-10-00084"><label>5</label>Department of Medicine Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy; <email>carlo.bicchi@unito.it</email></aff><author-notes><corresp id="c1-pharmaceuticals-10-00084"><label>*</label>Correspondence: <email>jwcalva@utpl.edu.ec</email>; Tel.: +593-7370-1444 (ext. 3049)</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><volume>10</volume><issue>4</issue><elocation-id>84</elocation-id><history><date date-type="received"><day>19</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>This study investigated the chemical composition, physical proprieties, biological activity, and enantiomeric analysis of the essential oil from the aerial parts of <italic>Niphogeton dissecta</italic> (culantrillo del cerro) from Ecuador, obtained by steam distillation. The qualitative and quantitative analysis of the essential oil was realized by gas chromatographic and spectroscopic techniques (GC-MS and GC-FID). Acorenone B was identified by GC-MS and NMR experiments. The enantiomeric distribution of some constituents has been assessed by enantio-GC through the use of a chiral cyclodextrin-based capillary column. We identified 41 components that accounted for 96.46% of the total analyzed, the major components were acorenone B (41.01%) and (E)-&#x003b2;-ocimene (29.64%). The enantiomeric ratio of (+)/(&#x02212;)-&#x003b2;-pinene was 86.9:13.1, while the one of (+)/(&#x02212;)-sabinene was 80.9:19.1. The essential oil showed a weak inhibitory activity, expressed as Minimal Inhibitory Concentration (MIC), against <italic>Enterococcus faecalis</italic> (MIC 10 mg/mL) and <italic>Staphylococcus aureus</italic> (MIC 5 mg/mL). Furthermore, it inhibited butyrylcholinesterase with an IC<sub>50</sub> value of 11.5 &#x003bc;g/mL. Pure acorenone B showed inhibitory activity against both acetylcholinesterase and butyrylcholinesterase, with IC<sub>50</sub> values of 40.8 &#x003bc;g/mL and 10.9 &#x003bc;g/mL, respectively.</p></abstract><kwd-group><kwd><italic>Niphogeton dissecta</italic></kwd><kwd>essential oil</kwd><kwd>enantiomeric distribution</kwd><kwd>acorenone B</kwd><kwd>AChE</kwd><kwd>BChE</kwd></kwd-group></article-meta></front><body><sec id="sec1-pharmaceuticals-10-00084"><title>1. Introduction</title><p>Medicinal plants have been used for a long time as sources of new pharmaceuticals due to the presence of bioactive compounds [<xref rid="B1-pharmaceuticals-10-00084" ref-type="bibr">1</xref>]. Plants are rich in structurally diverse secondary metabolites displaying a wide range of biological activities, including possible leads for the treatment of neurodegenerative diseases [<xref rid="B2-pharmaceuticals-10-00084" ref-type="bibr">2</xref>,<xref rid="B3-pharmaceuticals-10-00084" ref-type="bibr">3</xref>]. Natural products have contributed greatly as sources for drug discovery for Alzheimer&#x02019;s disease [<xref rid="B4-pharmaceuticals-10-00084" ref-type="bibr">4</xref>]. Earlier studies have shown that the maintenance of correct levels of acetylcholinesterases is directly related to different diseases such as Alzheimer's disease (AD), bipolar disorder, depression, and schizophrenia [<xref rid="B5-pharmaceuticals-10-00084" ref-type="bibr">5</xref>]. There are two distinct basic types of cholinesterases: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The main physiological function of AChE is the splitting of acetylcholine (ACh), a mediator of cholinergic synapses, during the transduction of nerve impulses [<xref rid="B6-pharmaceuticals-10-00084" ref-type="bibr">6</xref>].</p><p>AD is a prevalent disease that affects more than 26 million people globally, and is the most common neurodegenerative disease worldwide [<xref rid="B7-pharmaceuticals-10-00084" ref-type="bibr">7</xref>]. AChE inhibitors (AChEIs) have medical applications and are particularly important for the symptomatic treatment of Alzheimer&#x02019;s disease [<xref rid="B8-pharmaceuticals-10-00084" ref-type="bibr">8</xref>]. The butyrylcholinesterase enzyme (BChE) is synthesized in the liver and its main function is to hydrolyze hydrophobic and hydrophilic carboxylic or phosphoric acid ester containing compounds. Its toxicological and pharmacological importance becomes clear when an individual is exposured to poisonous compounds targeting the acetylcholine binding sites. When there is a hepatic alteration, its concentration decreases in direct relation with the altered hepatocytes [<xref rid="B9-pharmaceuticals-10-00084" ref-type="bibr">9</xref>,<xref rid="B10-pharmaceuticals-10-00084" ref-type="bibr">10</xref>].</p><p>The anti-AChE activity of the essential oils of <italic>Eryngium campestre</italic> and <italic>Eryngium amethystine,</italic> two species of the Apiaceae family, is described in the work conducted by Cianfaglione et al. [<xref rid="B11-pharmaceuticals-10-00084" ref-type="bibr">11</xref>], showing that the inhibitory activity is very low (10.5% at 19.5 mg/mL) compared to the commercial inhibitor galanthamine. The activity was expressed as galanthamine equivalent inhibitory activity and the dose tested is similar to an inhibition exerted by 3 &#x003bc;g/mL of the positive control galanthamine. Likewise, the essential oil of <italic>Daucus aristidis</italic> (Apiaceae) tested against AChE and BChE enzymes, by the Ellman method, at a concentration of 100 &#x003bc;g/mL appeared to have a moderate level of inhibitory effect (between 13% to 50%) against both enzymes as compared to that of galanthamine. The moderate AChE inhibitory activity of <italic>Daucus aristidis</italic> essential oil could be explained by the highest concentration of its individual components, &#x003b1;- and &#x003b2;-pinene (over 70%) [<xref rid="B12-pharmaceuticals-10-00084" ref-type="bibr">12</xref>].</p><p>Species belonging to the Apiaceae family such as cumin, coriander, carrot, celery, and parsley are considered foods or spices; however, some of them contain highly toxic substances [<xref rid="B13-pharmaceuticals-10-00084" ref-type="bibr">13</xref>]. <italic>Niphogeton dissecta</italic> is a native herb of the Ecuadorian Andes found at 2500&#x02013;4500 m above sea level [<xref rid="B14-pharmaceuticals-10-00084" ref-type="bibr">14</xref>], and is widely distributed in the provinces of Loja, Azuay, Ca&#x000f1;ar, Carchi, Chimborazo, Cotopaxi, Morona Santiago, Napo, Pichincha, and Zamora-Chinchipe. Traditionally, it is believed to have medicinal properties and it is used for the treatment of diarrhea, vomiting, inflammation of the belly, colds, and rheumatism [<xref rid="B15-pharmaceuticals-10-00084" ref-type="bibr">15</xref>].</p><p>The aim of the present study is to assess the potential antimicrobial, antifungal, and anticholinesterase (AChE and BChE) activity of the essential oil of <italic>Niphogeton dissecta</italic>, as well as to determine its chemical and physical properties. In addition, the phytochemical study of the essential oil led to the isolation and characterization of the known sesquiterpene acorenone B.</p></sec><sec id="sec2-pharmaceuticals-10-00084"><title>2. Results and Discussion</title><p>The essential oil of the aerial parts of <italic>Niphogeton dissecta</italic> was obtained by steam distillation for 4 h, yielding an average of 0.33 &#x000b1; 0.03% (<italic>w</italic>/<italic>w</italic>). The physical properties, chemical composition, enantiomeric analysis, and biological activity are discussed below.</p><sec id="sec2dot1-pharmaceuticals-10-00084"><title>2.1. Physical Properties</title><p>Three physical properties were determined: refractive index (<italic>n</italic> = 1.499 &#x000b1; 0.002), relative density (<italic>d</italic> = 0.906 &#x000b1; 0.012 g.m/L), and optical rotation (<inline-formula><mml:math id="mm1"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mo>&#x0221d;</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mi>D</mml:mi><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mn>7.50</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.98</mml:mn></mml:mrow></mml:mrow></mml:math></inline-formula> in CHCl<sub>3</sub>, c = 10.0). In this context, some authors state that the physical properties are determined by the genetic characteristics, geographical location, and phenological stages of the plant [<xref rid="B16-pharmaceuticals-10-00084" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceuticals-10-00084" ref-type="bibr">17</xref>].</p></sec><sec id="sec2dot2-pharmaceuticals-10-00084"><title>2.2. Chemical Composition</title><p>The chemical composition of the essential oil was defined based on calculated linear retention indices (LRIc) and mass spectra compared with literature [<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceuticals-10-00084" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceuticals-10-00084" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceuticals-10-00084" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceuticals-10-00084" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceuticals-10-00084" ref-type="bibr">23</xref>]. <xref ref-type="table" rid="pharmaceuticals-10-00084-t001">Table 1</xref> presents the components of the essential oil determined by GC-MS and quantified by GC-FID. Forty-one compounds were separated, which represented 96.46% of the total essential oil. The major compounds were acorenone B (41.01%), (E)-&#x003b2;-ocimene (29.64%), (3E)-butylidene phthalide (5.54%), and &#x003b1;-pinene (3.94%). Oxygenated sesquiterpenes (42.31%) and monoterpene hydrocarbons (37.97%) were the most representative groups. This is the first report on the characterization of the essential oil distilled from <italic>N. dissecta.</italic></p><p>A typical chromatogram of the essential oil from <italic>N. dissecta</italic> is shown in <xref ref-type="fig" rid="pharmaceuticals-10-00084-f001">Figure 1</xref>.</p></sec><sec id="sec2dot3-pharmaceuticals-10-00084"><title>2.3. Isolation and Characterization of Acorenone B</title><p>Acorenone B was isolated by column chromatography on silica gel G60 (1 kg). The mixture (5.0 g) was eluted in isocratic condition with hexane-ethyl acetate 90:10. The compound (1.48 g) was obtained as a pale yellow oil, with optical rotation <inline-formula><mml:math id="mm2"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mo>&#x0221d;</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mi>D</mml:mi><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mn>17.6</mml:mn></mml:mrow></mml:mrow></mml:math></inline-formula> (CHCl<sub>3</sub>; c = 11.4). Results similar to ours were reported by Zalkow [<xref rid="B24-pharmaceuticals-10-00084" ref-type="bibr">24</xref>].</p><p>The molecular structure of acorenone B (<xref ref-type="fig" rid="pharmaceuticals-10-00084-f002">Figure 2</xref>) was confirmed by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and MS analysis, and compared with data present in the literature [<xref rid="B24-pharmaceuticals-10-00084" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceuticals-10-00084" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceuticals-10-00084" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceuticals-10-00084" ref-type="bibr">27</xref>].</p><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), &#x003b4; (ppm): 0.74 (3H, d, <italic>J</italic> = 6.8 Hz, CH<sub>3</sub> of isopropyl), 0.83 (3H, d, <italic>J</italic> = 6.8 Hz, CH<sub>3</sub> of isopropyl), 0.92 (3H, d, <italic>J</italic> = 6.4 Hz, 4-CH<sub>3</sub>), 1.73 (3H, m, 8-CH<sub>3</sub>), 2.04 (1H, m, H-10), 2.20 (1H, m, H-6) 2.27 (1H, m, H-10), 2.67 (1H, m, H-6), 6.62 (1H, m, H-9).</p><p><sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>), &#x003b4; (ppm): 200.6 (C-7), 144.4 (C-9), 135.4 (C-8), 56.9 (C-1), 49.4 (C-6), 48.4 (C-5), 46.1 (C-4), 29.8 (C-3), 29.2 (C-11), 26.0 (C-10), 25.3 (C-2), 24.2 (C-13), 21.4 (C-14), 17.1 (C-12), 15.6 (C-15).</p><p>EI-MS <italic>m</italic>/<italic>z</italic> (%): 220 (M+, 58), 177 (76), 149 (45), 135 (100), 121 (60), 109 (100), 93 (46), 82 (84), 69 (28), 55 (22), 41 (29).</p><p>In our study, the fractionation of the essential oil of <italic>Niphogeton dissecta</italic> afforded a pure sequiterpene: acorenone B. Several authors reported the occurrence of acorenone B in other volatile fractions, such as the ones of <italic>Bothriochloa intermedia</italic> (47%) [<xref rid="B24-pharmaceuticals-10-00084" ref-type="bibr">24</xref>], <italic>Bothriochloa pertusa</italic> (9.8%) [<xref rid="B28-pharmaceuticals-10-00084" ref-type="bibr">28</xref>], <italic>Chaerophyllum hirsutum</italic> (9.47% to 18.49%) [<xref rid="B26-pharmaceuticals-10-00084" ref-type="bibr">26</xref>], <italic>Euphorbia macrorrhiza</italic> (16.72% and 25.80%) [<xref rid="B29-pharmaceuticals-10-00084" ref-type="bibr">29</xref>], <italic>Levisticum persicum</italic> (8.3% to 12.6%) [<xref rid="B30-pharmaceuticals-10-00084" ref-type="bibr">30</xref>], and as a major compound in <italic>Daucus littoralis subsp. Hyrcanicus</italic> (19.7% to 57.5% in all parts) [<xref rid="B31-pharmaceuticals-10-00084" ref-type="bibr">31</xref>], and <italic>Bothriochloa bladhii</italic> (18.2%) [<xref rid="B32-pharmaceuticals-10-00084" ref-type="bibr">32</xref>].</p><p>The occurrence of acorenone B in <italic>N. dissecta</italic> oil appears somewhat unusual because of the diversity of the sesquiterpenoid skeleton involved. According to Zalkow et al. [<xref rid="B24-pharmaceuticals-10-00084" ref-type="bibr">24</xref>], the proposed structure of acorenone B is considered to be derived from <italic>trans</italic>&#x02013;<italic>cis</italic>-farnesol via the &#x003b2;-bisabolyl cation.</p></sec><sec id="sec2dot4-pharmaceuticals-10-00084"><title>2.4. Enantiomeric Analysis</title><p>The enantiomeric distribution and enantiomeric excess (<italic>e.e.</italic>) (<xref ref-type="table" rid="pharmaceuticals-10-00084-t002">Table 2</xref>) of some chiral metabolites were determined on a cyclodextrine-based chiral stationary phase (MEGA-DEX-DET), comparing the retention time of separated enantiomers with enantiomerically pure standards. Two couples of chiral monoterpenoids were detected. The enantiomeric excesses of (+)-&#x003b2;-pinene and (+)-sabinene were quite considerable. These results further confirm that plants can also contain both enantiomers in the essential oil (<xref ref-type="fig" rid="pharmaceuticals-10-00084-f003">Figure 3</xref>).</p><p>It has been documented that sometimes different enantiomers may present dissimilar biological activities [<xref rid="B33-pharmaceuticals-10-00084" ref-type="bibr">33</xref>]. In our essential oil, the enantiomeric excess of (+)-&#x003b2;-pinene was 73.8% with respect to (&#x02013;)-&#x003b2;-pinene. Some studies have shown that the positive enantiomer has antimicrobial activity against <italic>Candida albicans, Cryptococcus neoformans, Rhyzopus oryzae</italic>, and methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) [<xref rid="B34-pharmaceuticals-10-00084" ref-type="bibr">34</xref>]. In contrast, the negative enantiomer exhibits antiviral properties against infectious bronchitis virus (IBV) [<xref rid="B35-pharmaceuticals-10-00084" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot5-pharmaceuticals-10-00084"><title>2.5. Antimicrobial Activity</title><p>The essential oil showed a weak inhibitory activity against <italic>Enterococcus faecalis</italic> and <italic>Staphylococcus aureus</italic>, while acorenone B was non-active at the maximum dose tested (10 mg/mL) (<xref ref-type="table" rid="pharmaceuticals-10-00084-t003">Table 3</xref>). According to Holetz et al. [<xref rid="B36-pharmaceuticals-10-00084" ref-type="bibr">36</xref>], an antibacterial activity is considered good when the Minimal Inhibitory Concentration (MIC) value is less than 100 &#x003bc;g/mL, demonstrating that both the essential oil and acorenone B do not show inhibitory activity against the evaluated strains.</p><p>The weak antimicrobial activity can be explained by the abundance of oxygenated sesquiterpenes in the investigated essential oil. In fact, hydrocarbon sesquiterpenes [<xref rid="B29-pharmaceuticals-10-00084" ref-type="bibr">29</xref>], carvacrol, thymol, eugenol, perylaldehyde, cinnamaldehyde, and cinnamic acid [<xref rid="B37-pharmaceuticals-10-00084" ref-type="bibr">37</xref>] are compounds generally more efficient as antimicrobial inhibitors.</p></sec><sec id="sec2dot6-pharmaceuticals-10-00084"><title>2.6. Cholinesterase Inhibition Test</title><p>In the present work, we also evaluated the anti-AChE and anti-BChE activities (<xref ref-type="table" rid="pharmaceuticals-10-00084-t004">Table 4</xref>). Acorenone B showed an inhibitory activity against AChE and BChE with IC<sub>50</sub> concentrations of 40.8 and 10.9 &#x003bc;g/mL, respectively (<xref ref-type="fig" rid="pharmaceuticals-10-00084-f004">Figure 4</xref>). These inhibitory potentials, even far from that of the reference compound donepezil (6.7 nM) versus AChE [<xref rid="B38-pharmaceuticals-10-00084" ref-type="bibr">38</xref>], are close to those previously published for galanthamine (2.2 &#x000b5;g/mL and 11.7 &#x000b5;g/mL) or other plant extracts [<xref rid="B4-pharmaceuticals-10-00084" ref-type="bibr">4</xref>,<xref rid="B39-pharmaceuticals-10-00084" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceuticals-10-00084" ref-type="bibr">40</xref>]. Interestingly, in spite of its moderate inhibitory potential, galanthamine is a typical drug used for the treatment of Alzheimer's disease [<xref rid="B41-pharmaceuticals-10-00084" ref-type="bibr">41</xref>], validating our efforts to identify new potential inhibitory compounds. <italic>Niphogeton dissecta</italic> essential oil exhibited selectivity for the inhibition of BChE, this property being particularly interesting in the treatment of Alzheimer's disease [<xref rid="B40-pharmaceuticals-10-00084" ref-type="bibr">40</xref>,<xref rid="B42-pharmaceuticals-10-00084" ref-type="bibr">42</xref>].</p></sec></sec><sec id="sec3-pharmaceuticals-10-00084"><title>3. Materials and Methods</title><sec id="sec3dot1-pharmaceuticals-10-00084"><title>3.1. Plant Material</title><p>The aerial parts of <italic>Niphogeton dissecta</italic> in flowering state were collected in September and October 2016 in the sector Loma la Torre, Loja, at an altitude of 3210 m a.s.l., with coordinates 696030 N, 9593252 E. The specimen was identified by Dr. Fani Tinitana of the UTPL herbarium, and deposited with voucher number 5835. The plant was collected under permission of the Ministry of Environment of Ecuador (MAE-DNB-CM-2016-0048).</p></sec><sec id="sec3dot2-pharmaceuticals-10-00084"><title>3.2. Extraction of Essential Oil</title><p>The essential oil was obtained from the aerial parts, by steam distillation in a Clevenger-type apparatus for 4 h. Four distillations were carried out with 1805, 751, 794, and 758 grams of fresh plant material, respectively. The oil was dried on anhydrous sodium sulfate and then stored at &#x02212;14 &#x000b0;C. The yield was expressed as mean values and standard deviations of the four distillations and reported as percentages of <italic>w</italic>/<italic>w</italic>.</p></sec><sec id="sec3dot3-pharmaceuticals-10-00084"><title>3.3. Physical Analysis</title><p>The relativity density (<italic>d</italic><sup>20</sup>) was determined using a 1-cm<sup>3</sup> pycnometer. The refractive index (<italic>n</italic><sup>20</sup>) was measured by an Abbe's refractometer, manufactured by Boeco, Germany. The specific optical rotation <inline-formula><mml:math id="mm3"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mo>&#x0221d;</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mi>D</mml:mi><mml:mrow><mml:mn>20</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> was determined in a Hanon P 810 automatic polarimeter. All these properties were expressed as mean values and standard deviations of four measurements.</p></sec><sec id="sec3dot4-pharmaceuticals-10-00084"><title>3.4. Gas Chromatography Coupled to Mass-Spectrometry (GC-MS)</title><p>The chemical constituents of the <italic>Niphogeton dissecta</italic> essential oil were analyzed on an Agilent Technologies 6890N gas chromatograph, coupled to a 5973N mass spectrometer (Santa Clara, CA, USA) and equipped with a DB-5MS capillary column (5%-phenyl-methylpolysiloxane, 30 m, 0.25 mm internal diameter., 0.25 &#x003bc;m film thickness; J &#x00026; W Scientific, Folsom, CA, USA). For the separation of the volatile constituents, the following temperature program was used: 5 min at 60 &#x000b0;C, 3 &#x000b0;C/min up to 165 &#x000b0;C, 15 &#x000b0;C/min up to 250 &#x000b0;C, and held for 10 min. The injector and detector temperatures were kept at 220 &#x000b0;C. The carrier gas was helium, at a flow rate of 1 mL/min. The injector was operated in split mode, with a split ratio of 1:50. The acquisition mass range was set at 40&#x02013;350 <italic>m</italic>/<italic>z</italic>. Ionization mode: electron-impact (70 eV). The essential oil was diluted 1:100 <italic>v</italic>/<italic>v</italic> in dichloromethane (Fisher Scientific, 99.9% purity) and 1 &#x000b5;L of the solution was injected.</p><p>For the identification of the essential oil components, linear retention indices were calculated according to Van Den Dool and Kratz. They were determined with a homologous series of linear alkanes (C9 from BDH, purity 99%, and C10&#x02013;C25 from Fluka, purity 99%).</p></sec><sec id="sec3dot5-pharmaceuticals-10-00084"><title>3.5. Gas Chromatography Coupled to Flame Ionization Detector (GC-FID)</title><p>Quantitative analysis of the essential oil was performed on an Agilent Technologies gas chromatograph (model 6890N) coupled to a flame ionization detector (FID) and using a 7683 series autoinjector (Agilent, Little Falls, DE, USA). The percentage composition of the oil was determined by correlating GC peak areas to the total chromatogram, without applying any correction factor, but normalizing values with nonane as an internal standard. The qualitative analysis is expressed as the mean values of four injections and standard deviations. The analytical parameters were the same as the GC-MS analysis.</p></sec><sec id="sec3dot6-pharmaceuticals-10-00084"><title>3.6. Enantioselective GC Analysis</title><p>Enantioselective GC-MS analysis was performed with the same Agilent Technologies instrument previously described. The mass spectrometer operated in electron impact ionization mode at 70 eV, with a mass range of <italic>m</italic>/<italic>z</italic> 40&#x02013;350 full scan mode. The ion source temperature was set at 220 &#x000b0;C. Helium was the carrier gas at a flow rate of 1.0 mL/min. The injector was operated in split mode (1:40) at 200 &#x000b0;C, with the transfer line at 230 &#x000b0;C. The oven thermal program was as follows: 60 &#x000b0;C for 2 min, then the temperature was raised to 220 &#x000b0;C with a gradient rate of 2 &#x000b0;C/min and held at 220 &#x000b0;C for 2 min. A chiral capillary column based on diethyl tertbutylsilyl-BETA-cyclodextrin (25m &#x000d7; 0.25mm &#x000d7; film thickness 0.25 &#x003bc;m) from Mega (Legnano, MI, Italy) was used. The essential oil was diluted 5:100 (<italic>v</italic>/<italic>v</italic>) in dichloromethane (Fisher Scientific, 99.9% purity) and 1 &#x000b5;L of the solution was injected. Enantiomerically pure standards, used to determine the elution order of enantiomers, were available in one of the authors' laboratory (C.B.).</p></sec><sec id="sec3dot7-pharmaceuticals-10-00084"><title>3.7. Isolation and Identification of Acorenone B</title><p>The essential oil of <italic>N. dissecta</italic> (5 g) was subjected to column chromatography over a silica gel G60 column, applying an oil/silica weight ratio of 1:200, with a mixture of Hex:AcOEt 90:10 (isocratic elution), obtaining a total of five fractions and affording acorenone B as a pure compound (1.48 g). The identification was performed by spectroscopic techniques such as EI-MS, <sup>1</sup>H, and <sup>13</sup>C NMR. <sup>1</sup>H and <sup>13</sup>C NMR spectra were acquired using a VARIAN NMR spectrometer (400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C), tetramethylsilane was used as an internal standard, and chemical shifts are given in &#x003b4; (ppm).</p></sec><sec id="sec3dot8-pharmaceuticals-10-00084"><title>3.8. Antimicrobial Activity</title><p>Five pathogenic bacteria (ATCC): <italic>Staphylococcus aureus</italic> ATCC 25923, <italic>E. faecalis</italic> ATCC 29212, <italic>Pseudomonas aeruginosa</italic> ATCC 27853, <italic>Escherichia coli</italic> ATCC 25922, <italic>Proteus vulgaris</italic> ATCC 8427, and <italic>Klebsiella pneumoniae</italic> ATCC 9997 were included in the investigation. For all bacteria, except for <italic>E. faecalis</italic>, a heart-heart infusion broth (BHI-DIFCO, DIFCO, Sparks, MD, USA) was used. All the strains were maintained at &#x02212;80 &#x000b0;C until use, when they were withdrawn to prepare overnight cultures at 37 &#x000b0;C for 16 h. MIC values were determined by the micro-dilution broth method, using a final concentration of 5/105 CFU/mL. DMSO solutions of the sample were prepared at a concentration of 20 mg/mL. Assays were carried out in 96-well plates and a two-fold serial dilution was used to obtain decreasing concentrations from 1000 to 0.024 mg/mL. The incubation was performed at 37 &#x000b0;C for 24 h. Gentamicin was used a positive control with an MIC value of 0.40 mg/mL, except for <italic>E. faecalis</italic> where ampicillin (MIC 1.56 mg/mL) was used.</p></sec><sec id="sec3dot9-pharmaceuticals-10-00084"><title>3.9. Cholinesterase Inhibition Test</title><p>The cholinesterase (ChE) activities were assayed following a colorimetric protocol adapted from Ellman et al. [<xref rid="B43-pharmaceuticals-10-00084" ref-type="bibr">43</xref>,<xref rid="B44-pharmaceuticals-10-00084" ref-type="bibr">44</xref>]. ChEs efficiently catalyze the hydrolysis of acetylthiocholine (ATCh), the sulfur analog of the natural substrate of these enzymes. Upon hydrolysis, this substrate analog produces acetate ion and thiocholine. Thiocholine, in the presence of the highly reactive dithiobisnitrobenzoate (DTNB) ion, generates a yellow color, which can be quantitatively monitored by spectrophotometric absorption at 412 nm. All reagents were obtained from the Sigma-Aldrich trading house. A typical 200 &#x003bc;L inhibition assay volume contained phosphate buffered saline solution (pH 7.4), DTNB (1.5 mM), test sample in DMSO (1% <italic>v/v</italic> final). Both acetylcholinesterase from <italic>Electrophorus electricus</italic> (Type V-S, lyophilized powder, 744 U/mg solid, 1 272 U/mg protein) and butyrylcholinesterase from equine serum (lyophilized powder, &#x02265;900 units/mg protein) were dissolved in PBS pH 7.4 and used at 25 mU/mL for the assay. After 10 min of pre-incubation, the substrate acetylthiocholine iodide (1.5 mM) was added to start the reaction. During 1 h of incubation at 30 &#x000b0;C, 96-well microtiter multiplates were read on a PherastarFS (BMG Labtech) detection system. All measurements were made in triplicate. When possible, the IC<sub>50</sub> values were calculated using the GNUPLOT package on line (<uri xlink:href="www.ic50.tk">www.ic50.tk</uri>, <uri xlink:href="www.gnuplot.info">www.gnuplot.info</uri>). Donepezil was used as reference ChE inhibitor with an IC<sub>50</sub> = 100 nM for AChE and 8500 nM for BChE. In this assay, we did not exclude the possibility of false-positive inhibition results previously described for high concentrations (&#x0003e;100 &#x003bc;g/mL) of amine or aldehyde compounds [<xref rid="B45-pharmaceuticals-10-00084" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceuticals-10-00084" ref-type="bibr">46</xref>], but the lack of inhibition observed for the essential oil versus the AChE strongly minimized this possibility.</p></sec></sec><sec id="sec4-pharmaceuticals-10-00084"><title>4. Conclusions</title><p>The physical properties, chemical composition, biological activity, and enantiomeric distribution of the essential oil distilled from <italic>Niphogeton dissecta</italic> were determined for the first time. Forty-one compounds, representing 96.46% of the total oil, were identified. The major compounds were acorenone B (41.01%), (E)-&#x003b2;-ocimene (29.64%), (3E)-butylidene phthalide (5.54%), and &#x003b1;-pinene (3.94%). The whole volatile fraction and its pure major constituent were assayed for two biological activities: inhibition of two bacteria strains and enzymatic inhibition against AChE and BChE. Concerning the first activity, the oil showed an MIC value of 10 mg/mL against <italic>Enterococcus faecalis</italic> and 5 mg/mL against <italic>Staphylococcus aureus</italic>. No activity was detected for pure acorenone B. Concerning the enzymatic inhibition, the Essential Oil (E.O.) showed an IC<sub>50</sub> value of 11.5 &#x003bc;g/mL in the inhibition of BChE and no inhibition of AChE. On the other hand, acorenone B was active against both enzymes, with an IC<sub>50</sub> of 40.8 &#x003bc;g/mL for AChE and 10.9 &#x003bc;g/mL for BChE. The chiral analysis of the E.O. indicated the following enantiomeric distribution: (+)-&#x003b2;-pinene (86.9%), (&#x02212;)-&#x003b2;-pinene (13.1%), (+)-sabinene (80.9%), and (&#x02212;)-sabinene (19.1%).</p></sec></body><back><ack><title>Acknowledgments</title><p>We are very grateful to the Master Program in Applied Chemistry of the Universidad T&#x000e9;cnica Particular de Loja, Ecuador, for financial support.</p></ack><notes><title>Author Contributions</title><p>All of the authors listed in this work provided academic contributions to the development of this manuscript: James Calva, Gianluca Gilardoni, and Jos&#x000e9; Vinicio Montesinos collected the plant material and performed the hydrodistillation; James Calva performed the chemical analyses and wrote the article; Gianluca Gilardoni supervised the experiments and interpreted analytical data; Nicole Bec, Christian Larroque, and Luis Cartuche conducted the biological activity tests; Carlo Bicchi furnished enantiomerically pure standards and gave technical support to chiral analysis. All the authors have revised and approved the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-10-00084"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S.K.</given-names></name><name><surname>Mohanta</surname><given-names>Y.K.</given-names></name><name><surname>Padhi</surname><given-names>L.</given-names></name><name><surname>Park</surname><given-names>Y.H.</given-names></name><name><surname>Mohanta</surname><given-names>T.K.</given-names></name><name><surname>Bae</surname><given-names>H.</given-names></name></person-group><article-title>Large scale screening of ethnomedicinal plants for identification of potential antibacterial compounds</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>293</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21030293</pub-id><?supplied-pmid 26985889?><pub-id pub-id-type="pmid">26985889</pub-id></element-citation></ref><ref id="B2-pharmaceuticals-10-00084"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>L.P.</given-names></name><name><surname>Brandt</surname><given-names>K.</given-names></name></person-group><article-title>Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity and analysis</article-title><source>J. Pharm. Biomed. Anal.</source><year>2006</year><volume>41</volume><fpage>683</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2006.01.057</pub-id><?supplied-pmid 16520011?><pub-id pub-id-type="pmid">16520011</pub-id></element-citation></ref><ref id="B3-pharmaceuticals-10-00084"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanafy</surname><given-names>D.M.</given-names></name><name><surname>Prenzler</surname><given-names>P.D.</given-names></name><name><surname>Burrows</surname><given-names>G.E.</given-names></name><name><surname>Ryan</surname><given-names>D.</given-names></name><name><surname>Nielsen</surname><given-names>S.</given-names></name><name><surname>El Sawi</surname><given-names>S.A.</given-names></name><name><surname>Obied</surname><given-names>H.K.</given-names></name></person-group><article-title>Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer&#x02019;s disease treatment</article-title><source>J. Funct. Foods</source><year>2017</year><volume>33</volume><fpage>345</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.03.027</pub-id></element-citation></ref><ref id="B4-pharmaceuticals-10-00084"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadaeinasab</surname><given-names>M.</given-names></name><name><surname>Hadi</surname><given-names>A.H.A.</given-names></name><name><surname>Kia</surname><given-names>Y.</given-names></name><name><surname>Basiri</surname><given-names>A.</given-names></name><name><surname>Murugaiyah</surname><given-names>V.</given-names></name></person-group><article-title>Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>3779</fpage><lpage>3788</lpage><pub-id pub-id-type="doi">10.3390/molecules18043779</pub-id><?supplied-pmid 23529036?><pub-id pub-id-type="pmid">23529036</pub-id></element-citation></ref><ref id="B5-pharmaceuticals-10-00084"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zachow</surname><given-names>L.L.</given-names></name><name><surname>&#x000c1;vila</surname><given-names>J.M.</given-names></name><name><surname>Saldanha</surname><given-names>G.A.</given-names></name><name><surname>Mostardeiro</surname><given-names>M.A.</given-names></name><name><surname>da Silva</surname><given-names>U.F.</given-names></name><name><surname>Morel</surname><given-names>A.F.</given-names></name><name><surname>Dalcol</surname><given-names>I.I.</given-names></name></person-group><article-title>Chemical composition and evaluation of prolyl oligopeptidase and acetylcholinesterase inhibitory activities of Leonurus Sibiricus L. from Brazil</article-title><source>Nat. Prod. Res.</source><year>2017</year><volume>31</volume><fpage>1459</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1080/14786419.2016.1255890</pub-id><?supplied-pmid 27834099?><pub-id pub-id-type="pmid">27834099</pub-id></element-citation></ref><ref id="B6-pharmaceuticals-10-00084"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuiko</surname><given-names>G.</given-names></name><name><surname>Podgornaya</surname><given-names>V.</given-names></name><name><surname>Zhelnin</surname><given-names>Y.</given-names></name></person-group><article-title>Acetylcholinesterase and butyrylcholinesterase activities in brain and plasma of freshwater teleosts: Cross-species and cross-family differences</article-title><source>Comp. Biochem. Physiol. Part B Biochem. Mol. Biol.</source><year>2003</year><volume>135</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S1096-4959(03)00048-4</pub-id></element-citation></ref><ref id="B7-pharmaceuticals-10-00084"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manalo</surname><given-names>R.V.</given-names></name><name><surname>Silvestre</surname><given-names>M.A.</given-names></name><name><surname>Barbosa</surname><given-names>A.L.A.</given-names></name><name><surname>Medina</surname><given-names>P.M.</given-names></name></person-group><article-title>Coconut (<italic>Cocos nucifera</italic>) Ethanolic Leaf Extract Reduces Amyloid-&#x003b2; (1&#x02013;42) Aggregation and Paralysis Prevalence in Transgenic Caenorhabditis elegans Independently of Free Radical Scavenging and Acetylcholinesterase Inhibition</article-title><source>Biomedicines</source><year>2017</year><volume>5</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines5020017</pub-id><?supplied-pmid 28536360?><pub-id pub-id-type="pmid">28536360</pub-id></element-citation></ref><ref id="B8-pharmaceuticals-10-00084"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ak&#x00131;nc&#x00131;o&#x0011f;lu</surname><given-names>A.</given-names></name><name><surname>Ak&#x00131;nc&#x00131;o&#x0011f;lu</surname><given-names>H.</given-names></name><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name><name><surname>Durdagi</surname><given-names>S.</given-names></name><name><surname>Supuran</surname><given-names>C.T.</given-names></name><name><surname>G&#x000f6;ksu</surname><given-names>S.</given-names></name></person-group><article-title>Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: Novel sulfamoylcarbamates and sulfamides derived from acetophenones</article-title><source>Bioorg. Med. Chem.</source><year>2015</year><volume>23</volume><fpage>3592</fpage><lpage>3602</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2015.04.019</pub-id><?supplied-pmid 25921269?><pub-id pub-id-type="pmid">25921269</pub-id></element-citation></ref><ref id="B9-pharmaceuticals-10-00084"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>V&#x000e1;squez</surname><given-names>L.</given-names></name><name><surname>Osorio</surname><given-names>J.</given-names></name></person-group><article-title>Variaci&#x000f3;n de la actividad de la enzima Butirilcolinesterasa en usuarias de anticonceptivos hormonales</article-title><source>Anales de la Facultad de Medicina</source><publisher-name>Universidad Nacional Mayor de San Marcos</publisher-name><publisher-loc>Lima, Peru</publisher-loc><year>2000</year></element-citation></ref><ref id="B10-pharmaceuticals-10-00084"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c7;oku&#x0011f;ra&#x0015f;</surname><given-names>A.N.</given-names></name></person-group><article-title>Butyrylcholinesterase: structure and physiological importance</article-title><source>Turk. J. Biochem.</source><year>2003</year><volume>28</volume><fpage>54</fpage><lpage>61</lpage></element-citation></ref><ref id="B11-pharmaceuticals-10-00084"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cianfaglione</surname><given-names>K.</given-names></name><name><surname>Blomme</surname><given-names>E.E.</given-names></name><name><surname>Quassinti</surname><given-names>L.</given-names></name><name><surname>Bramucci</surname><given-names>M.</given-names></name><name><surname>Lupidi</surname><given-names>G.</given-names></name><name><surname>Dall&#x02019;Acqua</surname><given-names>S.</given-names></name><name><surname>Maggi</surname><given-names>F.</given-names></name></person-group><article-title>Cytotoxic Essential Oils from Eryngium campestre and Eryngium amethystinum (Apiaceae) Growing in Central Italy</article-title><source>Chem. Biodivers.</source><year>2017</year><volume>14</volume><fpage>e1700096</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201700096</pub-id><?supplied-pmid 28332760?><pub-id pub-id-type="pmid">28332760</pub-id></element-citation></ref><ref id="B12-pharmaceuticals-10-00084"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamamra</surname><given-names>M.</given-names></name><name><surname>Laouer</surname><given-names>H.</given-names></name><name><surname>Amira</surname><given-names>S.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Senol</surname><given-names>F.S.</given-names></name><name><surname>Demirci</surname><given-names>B.</given-names></name><name><surname>Akkal</surname><given-names>S.</given-names></name></person-group><article-title>Chemical Composition and Cholinesterase Inhibitory Activity of Different Parts of Daucus aristidis Coss. Essential Oils from Two Locations in Algeria</article-title><source>Rec. Natl. Prod.</source><year>2017</year><volume>11</volume><fpage>147</fpage></element-citation></ref><ref id="B13-pharmaceuticals-10-00084"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldemir</surname><given-names>A.</given-names></name><name><surname>Top&#x000e7;u</surname><given-names>H.</given-names></name><name><surname>Paksoy</surname><given-names>M.Y.</given-names></name><name><surname>Motalebipour</surname><given-names>E.Z.</given-names></name><name><surname>Kafkas</surname><given-names>S.</given-names></name></person-group><article-title>First microsatellite markers for Scaligeria lazica Boiss.(Apiaceae) by next-generation sequencing: Population structure and genetic diversity analysis</article-title><source>Biotechnol. Biotechnol. Equip.</source><year>2017</year><volume>31</volume><fpage>535</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1080/13102818.2017.1301784</pub-id></element-citation></ref><ref id="B14-pharmaceuticals-10-00084"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izco</surname><given-names>J.</given-names></name><name><surname>Pulgar</surname><given-names>&#x000cd;.</given-names></name><name><surname>Aguirre</surname><given-names>Z.</given-names></name><name><surname>Santin</surname><given-names>F.</given-names></name></person-group><article-title>Estudio flor&#x000ed;stico de los p&#x000e1;ramos de pajonal meridionales de Ecuador</article-title><source>Rev. Peru. Biol.</source><year>2007</year><volume>14</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.15381/rpb.v14i2.1783</pub-id></element-citation></ref><ref id="B15-pharmaceuticals-10-00084"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abad</surname><given-names>X.</given-names></name></person-group><source>Determinaci&#x000f3;n de la Actividad Antimicrobiana de los Extractos Totales de Cuatro Especies Vegetales de las Provincias de Loja y Zamora Chinchipe: Piper ecuadorense (Matico), Lepechinia mutica Benth (Turuyante), Fuschia ayavacensis (Pena-Pena), Niphogeton dissecta (Culantrillo del cerro), Empleando los M&#x000e9;todos de Difusi&#x000f3;n en Placa, Concentraci&#x000f3;n M&#x000ed;nima Inhibitoria e Inhibici&#x000f3;n del Crecimiento Radial</source><publisher-name>Departamento de Qu&#x000ed;mica, Universidad T&#x000e9;cnica Particular de Loja</publisher-name><publisher-loc>Loja, Ecuador</publisher-loc><year>2009</year><fpage>88</fpage></element-citation></ref><ref id="B16-pharmaceuticals-10-00084"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajabi</surname><given-names>Z.</given-names></name><name><surname>Ebrahimi</surname><given-names>M.</given-names></name><name><surname>Farajpour</surname><given-names>M.</given-names></name><name><surname>Mirza</surname><given-names>M.</given-names></name><name><surname>Ramshini</surname><given-names>H.</given-names></name></person-group><article-title>Compositions and yield variation of essential oils among and within nine Salvia species from various areas of Iran</article-title><source>Ind. Crops Prod.</source><year>2014</year><volume>61</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2014.06.038</pub-id></element-citation></ref><ref id="B17-pharmaceuticals-10-00084"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benyelles</surname><given-names>B.</given-names></name><name><surname>Allali</surname><given-names>H.</given-names></name><name><surname>Dib</surname><given-names>M.E.A.</given-names></name><name><surname>Djabou</surname><given-names>N.</given-names></name><name><surname>Paolini</surname><given-names>J.</given-names></name><name><surname>Costa</surname><given-names>J.</given-names></name></person-group><article-title>Chemical Composition Variability of Essential Oils of <italic>Daucus gracilis</italic> Steinh. from Algeria</article-title><source>Chem. Biodivers.</source><year>2017</year><pub-id pub-id-type="doi">10.1002/cbdv.201600490</pub-id><?supplied-pmid 28212458?><pub-id pub-id-type="pmid">28212458</pub-id></element-citation></ref><ref id="B18-pharmaceuticals-10-00084"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>R.P.</given-names></name></person-group><source>Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry</source><edition>4th ed.</edition><publisher-name>Allured Publishing Corporation</publisher-name><publisher-loc>Carol Stream, IL, USA</publisher-loc><year>2009</year></element-citation></ref><ref id="B19-pharmaceuticals-10-00084"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angioni</surname><given-names>A.</given-names></name><name><surname>Barra</surname><given-names>A.</given-names></name><name><surname>Coroneo</surname><given-names>V.</given-names></name><name><surname>Dessi</surname><given-names>S.</given-names></name><name><surname>Cabras</surname><given-names>P.</given-names></name></person-group><article-title>Chemical composition, seasonal variability, and antifungal activity of <italic>Lavandula stoechas</italic> L. ssp. stoechas essential oils from stem/leaves and flowers</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>4364</fpage><lpage>4370</lpage><?supplied-pmid 16756368?><pub-id pub-id-type="pmid">16756368</pub-id></element-citation></ref><ref id="B20-pharmaceuticals-10-00084"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalali-Heravi</surname><given-names>M.</given-names></name><name><surname>Zekavat</surname><given-names>B.</given-names></name><name><surname>Sereshti</surname><given-names>H.</given-names></name></person-group><article-title>Characterization of essential oil components of Iranian geranium oil using gas chromatography&#x02013;mass spectrometry combined with chemometric resolution techniques</article-title><source>J. Chromatogr. A</source><year>2006</year><volume>1114</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2006.02.034</pub-id><?supplied-pmid 16545828?><pub-id pub-id-type="pmid">16545828</pub-id></element-citation></ref><ref id="B21-pharmaceuticals-10-00084"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marongiu</surname><given-names>B.</given-names></name><name><surname>Piras</surname><given-names>A.</given-names></name><name><surname>Porcedda</surname><given-names>S.</given-names></name><name><surname>Scorciapino</surname><given-names>A.</given-names></name></person-group><article-title>Chemical composition of the essential oil and supercritical CO<sub>2</sub> extract of <italic>Commiphora myrrha</italic> (Nees) Engl. and of <italic>Acorus calamus</italic> L.</article-title><source>J. Agric. Food Chem.</source><year>2005</year><volume>53</volume><fpage>7939</fpage><lpage>7943</lpage><pub-id pub-id-type="doi">10.1021/jf051100x</pub-id><?supplied-pmid 16190653?><pub-id pub-id-type="pmid">16190653</pub-id></element-citation></ref><ref id="B22-pharmaceuticals-10-00084"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammami</surname><given-names>I.</given-names></name><name><surname>Triki</surname><given-names>M.A.</given-names></name><name><surname>Rebai</surname><given-names>A.</given-names></name></person-group><article-title>Chemical compositions, antibacterial and antioxidant activities of essential oil and various extracts of <italic>Geranium sanguineum</italic> L. flowers</article-title><source>Arch. Appl. Sci. Res.</source><year>2011</year><volume>3</volume><fpage>135</fpage><lpage>144</lpage></element-citation></ref><ref id="B23-pharmaceuticals-10-00084"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaltsa</surname><given-names>H.D.</given-names></name><name><surname>Mavrommati</surname><given-names>A.</given-names></name><name><surname>Constantinidis</surname><given-names>T.</given-names></name></person-group><article-title>A chemotaxonomic investigation of volatile constituents in Stachys subsect. Swainsonianeae (Labiatae)</article-title><source>Phytochemistry</source><year>2001</year><volume>57</volume><fpage>235</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(01)00003-6</pub-id><pub-id pub-id-type="pmid">11382239</pub-id></element-citation></ref><ref id="B24-pharmaceuticals-10-00084"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalkow</surname><given-names>L.H.</given-names></name><name><surname>Baxter</surname><given-names>J.T.</given-names></name><name><surname>McClure</surname><given-names>R.J.</given-names></name><name><surname>Gordon</surname><given-names>M.M.</given-names></name></person-group><article-title>A Phytochemical Investigation of Bothriochloa intermedia</article-title><source>J. Natl. Prod.</source><year>1980</year><volume>43</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1021/np50011a013</pub-id></element-citation></ref><ref id="B25-pharmaceuticals-10-00084"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefbeyk</surname><given-names>F.</given-names></name><name><surname>Golfakhrabadi</surname><given-names>F.</given-names></name><name><surname>Amouei</surname><given-names>A.</given-names></name><name><surname>Ghasemi</surname><given-names>S.</given-names></name><name><surname>Amin</surname><given-names>M.</given-names></name><name><surname>Gohari</surname><given-names>A.</given-names></name><name><surname>Samadi</surname><given-names>N.</given-names></name><name><surname>Amini</surname><given-names>M.</given-names></name><name><surname>Amin</surname><given-names>G.</given-names></name></person-group><article-title>Phytochemical Investigation and Antifungal Activity of <italic>Daucus littoralis</italic> Smith sub sp. hyrcanicus Rech. f.</article-title><source>Res. J. Phytochem.</source><year>2015</year><volume>9</volume><fpage>33</fpage><lpage>44</lpage></element-citation></ref><ref id="B26-pharmaceuticals-10-00084"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubeczka</surname><given-names>K.-H.</given-names></name><name><surname>Bohn</surname><given-names>I.</given-names></name><name><surname>Schultze</surname><given-names>W.</given-names></name><name><surname>Forma&#x0010d;ek</surname><given-names>V.</given-names></name></person-group><article-title>The Composition of the Essential Oils of <italic>Chaerophyllum hirsutum</italic> L.</article-title><source>J. Essent. Oil Res.</source><year>1989</year><volume>1</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1080/10412905.1989.9697795</pub-id></element-citation></ref><ref id="B27-pharmaceuticals-10-00084"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>B.M.</given-names></name><name><surname>Morton</surname><given-names>J.K.</given-names></name></person-group><article-title>Acorenone-B in Angelica lucida oil</article-title><source>Phytochemistry</source><year>1974</year><volume>13</volume><fpage>528</fpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)91256-1</pub-id></element-citation></ref><ref id="B28-pharmaceuticals-10-00084"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaul</surname><given-names>V.K.</given-names></name><name><surname>Vats</surname><given-names>S.</given-names></name></person-group><article-title>Essential oil composition of <italic>Bothriochloa pertusa</italic> and phyletic relationship in aromatic grasses</article-title><source>Biochem. Syst. Ecol.</source><year>1998</year><volume>26</volume><fpage>347</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/S0305-1978(97)00103-8</pub-id></element-citation></ref><ref id="B29-pharmaceuticals-10-00084"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Dou</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Aisa</surname><given-names>H.A.</given-names></name></person-group><article-title>Chemical composition, antimicrobial and antitumor activities of the essential oils and crude extracts of Euphorbia macrorrhiza</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>5030</fpage><lpage>5039</lpage><pub-id pub-id-type="doi">10.3390/molecules17055030</pub-id><?supplied-pmid 22555293?><pub-id pub-id-type="pmid">22555293</pub-id></element-citation></ref><ref id="B30-pharmaceuticals-10-00084"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafaghat</surname><given-names>A.</given-names></name></person-group><article-title>Chemical constituents, antimicrobial and antioxidant activity of the hexane extract from root and seed of <italic>Levisticum persicum</italic> Freyn and Bornm</article-title><source>J. Med. Plants Res.</source><year>2011</year><volume>5</volume><fpage>5127</fpage><lpage>5131</lpage></element-citation></ref><ref id="B31-pharmaceuticals-10-00084"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefbeyk</surname><given-names>F.</given-names></name><name><surname>Gohari</surname><given-names>A.R.</given-names></name><name><surname>Sourmaghi</surname><given-names>M.H.S.</given-names></name><name><surname>Amini</surname><given-names>M.</given-names></name><name><surname>Jamalifar</surname><given-names>H.</given-names></name><name><surname>Amin</surname><given-names>M.</given-names></name><name><surname>Golfakhrabadi</surname><given-names>F.</given-names></name><name><surname>Ramezani</surname><given-names>N.</given-names></name><name><surname>Amin</surname><given-names>G.</given-names></name></person-group><article-title>Chemical Composition and Antimicrobial Activity of Essential Oils from Different Parts of <italic>Daucus littoralis</italic> Smith subsp. <italic>hyrcanicus</italic> Rech. f.</article-title><source>J. Essent. Oil Bear. Plants</source><year>2014</year><volume>17</volume><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2014.901610</pub-id></element-citation></ref><ref id="B32-pharmaceuticals-10-00084"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahl</surname><given-names>J.</given-names></name><name><surname>Padalia</surname><given-names>R.C.</given-names></name><name><surname>Verma</surname><given-names>R.S.</given-names></name><name><surname>Bansal</surname><given-names>R.P.</given-names></name></person-group><article-title>Essential Oil Composition of <italic>Bothriochloa bladhii</italic> (Retz.) ST Blake: An Introduction from Tropical Region of Western Ghats of India</article-title><source>J. Essent. Oil Bear. Plants</source><year>2014</year><volume>17</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2014.884814</pub-id></element-citation></ref><ref id="B33-pharmaceuticals-10-00084"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Fern&#x000e1;ndez</surname><given-names>V.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>M.&#x000c1;.</given-names></name><name><surname>Marina</surname><given-names>M.L.</given-names></name></person-group><article-title>Characteristics and enantiomeric analysis of chiral pyrethroids</article-title><source>J. Chromatogr. A</source><year>2010</year><volume>1217</volume><fpage>968</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2009.10.069</pub-id><?supplied-pmid 19922941?><pub-id pub-id-type="pmid">19922941</pub-id></element-citation></ref><ref id="B34-pharmaceuticals-10-00084"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>A.C.R.D.</given-names></name><name><surname>Lopes</surname><given-names>P.M.</given-names></name><name><surname>Azevedo</surname><given-names>M.M.B.D.</given-names></name><name><surname>Costa</surname><given-names>D.C.M.</given-names></name><name><surname>Alviano</surname><given-names>C.S.</given-names></name><name><surname>Alviano</surname><given-names>D.S.</given-names></name></person-group><article-title>Biological activities of a-pinene and &#x003b2;-pinene enantiomers</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>6305</fpage><lpage>6316</lpage><pub-id pub-id-type="doi">10.3390/molecules17066305</pub-id><?supplied-pmid 23442885?><pub-id pub-id-type="pmid">23442885</pub-id></element-citation></ref><ref id="B35-pharmaceuticals-10-00084"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Zu</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name></person-group><article-title>Comparative Anti-Infectious Bronchitis Virus (IBV) Activity of (&#x02212;)-Pinene: Effect on Nucleocapsid (N) Protein</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>1044</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.3390/molecules16021044</pub-id><?supplied-pmid 21350392?><pub-id pub-id-type="pmid">21350392</pub-id></element-citation></ref><ref id="B36-pharmaceuticals-10-00084"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holetz</surname><given-names>F.B.</given-names></name><name><surname>Pessini</surname><given-names>G.L.</given-names></name><name><surname>Sanches</surname><given-names>N.R.</given-names></name><name><surname>Cortez</surname><given-names>D.A.G.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name><name><surname>Dias Filho</surname><given-names>B.P.</given-names></name></person-group><article-title>Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases</article-title><source>Mem&#x000f3;rias Instituto Oswaldo Cruz</source><year>2002</year><volume>97</volume><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762002000700017</pub-id></element-citation></ref><ref id="B37-pharmaceuticals-10-00084"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils: Their antibacterial properties and potential applications in foods&#x02014;A review</article-title><source>Int. J. Food Microbiol.</source><year>2004</year><volume>94</volume><fpage>223</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2004.03.022</pub-id><?supplied-pmid 15246235?><pub-id pub-id-type="pmid">15246235</pub-id></element-citation></ref><ref id="B38-pharmaceuticals-10-00084"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>H.</given-names></name><name><surname>Kosasa</surname><given-names>T.</given-names></name><name><surname>Kuriya</surname><given-names>Y.</given-names></name><name><surname>Yamanishi</surname><given-names>Y.</given-names></name></person-group><article-title>Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro</article-title><source>Methods Find. Exp. Clin. Pharmacol.</source><year>2000</year><volume>22</volume><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1358/mf.2000.22.8.701373</pub-id><?supplied-pmid 11256231?><pub-id pub-id-type="pmid">11256231</pub-id></element-citation></ref><ref id="B39-pharmaceuticals-10-00084"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>P.</given-names></name><name><surname>Grosso</surname><given-names>C.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>P.B.</given-names></name><name><surname>Valent&#x000e3;o</surname><given-names>P.</given-names></name><name><surname>Bernardo-Gil</surname><given-names>M.G.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name></person-group><article-title>Supercritical fluid extraction and hydrodistillation for the recovery of bioactive compounds from Lavandula viridis L&#x02019;H&#x000e9;r</article-title><source>Food Chem.</source><year>2012</year><volume>135</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.04.108</pub-id></element-citation></ref><ref id="B40-pharmaceuticals-10-00084"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeb</surname><given-names>A.</given-names></name><name><surname>Hameed</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>L.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Dalvandi</surname><given-names>K.</given-names></name><name><surname>Iqbal Choudhary</surname><given-names>M.</given-names></name><name><surname>Basha</surname><given-names>F.Z.</given-names></name></person-group><article-title>Quinoxaline derivatives: Novel and selective butyrylcholinesterase inhibitors</article-title><source>Med. Chem.</source><year>2014</year><volume>10</volume><fpage>724</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.2174/1573406410666140526145429</pub-id><?supplied-pmid 24875826?><pub-id pub-id-type="pmid">24875826</pub-id></element-citation></ref><ref id="B41-pharmaceuticals-10-00084"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloniecki</surname><given-names>V.</given-names></name><name><surname>Aarsland</surname><given-names>D.</given-names></name><name><surname>Blennow</surname><given-names>K.</given-names></name><name><surname>Cummings</surname><given-names>J.</given-names></name><name><surname>Falahati</surname><given-names>F.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Freund-Levi</surname><given-names>Y.</given-names></name></person-group><article-title>Effects of Risperidone and Galantamine Treatment on Alzheimer&#x02019;s Disease Biomarker Levels in Cerebrospinal Fluid</article-title><source>J. Alzheimer's Dis.</source><year>2017</year><volume>57</volume><fpage>387</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.3233/JAD-160758</pub-id><?supplied-pmid 28269767?><pub-id pub-id-type="pmid">28269767</pub-id></element-citation></ref><ref id="B42-pharmaceuticals-10-00084"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greig</surname><given-names>N.H.</given-names></name><name><surname>Utsuki</surname><given-names>T.</given-names></name><name><surname>Ingram</surname><given-names>D.K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pepeu</surname><given-names>G.</given-names></name><name><surname>Scali</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>Q.S.</given-names></name><name><surname>Mamczarz</surname><given-names>J.</given-names></name><name><surname>Holloway</surname><given-names>H.W.</given-names></name><name><surname>Giordano</surname><given-names>T.</given-names></name></person-group><article-title>Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer &#x003b2;-amyloid peptide in rodent</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>17213</fpage><lpage>17218</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508575102</pub-id><?supplied-pmid 16275899?><pub-id pub-id-type="pmid">16275899</pub-id></element-citation></ref><ref id="B43-pharmaceuticals-10-00084"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellman</surname><given-names>G.L.</given-names></name><name><surname>Courtney</surname><given-names>K.D.</given-names></name><name><surname>Andres</surname><given-names>V.</given-names></name><name><surname>Featherstone</surname><given-names>R.M.</given-names></name></person-group><article-title>A new and rapid colorimetric determination of acetylcholinesterase activity</article-title><source>Biochem. Pharmacol.</source><year>1961</year><volume>7</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(61)90145-9</pub-id><pub-id pub-id-type="pmid">13726518</pub-id></element-citation></ref><ref id="B44-pharmaceuticals-10-00084"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armijos</surname><given-names>C.</given-names></name><name><surname>Gilardoni</surname><given-names>G.</given-names></name><name><surname>Amay</surname><given-names>L.</given-names></name><name><surname>Lozano</surname><given-names>A.</given-names></name><name><surname>Bracco</surname><given-names>F.</given-names></name><name><surname>Ramirez</surname><given-names>J.</given-names></name><name><surname>Bec</surname><given-names>N.</given-names></name><name><surname>Larroque</surname><given-names>C.</given-names></name><name><surname>Vita Finzi</surname><given-names>P.V.</given-names></name><name><surname>Vidari</surname><given-names>G.</given-names></name></person-group><article-title>Phytochemical and ethnomedicinal study of Huperzia species used in the traditional medicine of Saraguros in Southern Ecuador; AChE and MAO inhibitory activity</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>193</volume><fpage>546</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.09.049</pub-id><?supplied-pmid 27686269?><pub-id pub-id-type="pmid">27686269</pub-id></element-citation></ref><ref id="B45-pharmaceuticals-10-00084"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>I.K.</given-names></name><name><surname>Van Rijn</surname><given-names>R.M.</given-names></name><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group><article-title>Qualitative determination of false positive effects in the acetylcholinesterase assays using thin layer chromatography</article-title><source>Phytochem. Anal.</source><year>2003</year><volume>14</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1002/pca.675</pub-id><?supplied-pmid 12793457?><pub-id pub-id-type="pmid">12793457</pub-id></element-citation></ref><ref id="B46-pharmaceuticals-10-00084"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>I.K.</given-names></name><name><surname>van de Meent</surname><given-names>M.</given-names></name><name><surname>Ingkaninan</surname><given-names>K.</given-names></name><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group><article-title>Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining</article-title><source>J. Chromatogr. A</source><year>2001</year><volume>915</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(01)00624-0</pub-id><pub-id pub-id-type="pmid">11358251</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pharmaceuticals-10-00084-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Typical gas-chromatogram of essential oil of <italic>Niphogeton dissecta</italic>.</p></caption><graphic xlink:href="pharmaceuticals-10-00084-g001"/></fig><fig id="pharmaceuticals-10-00084-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structure of acorenone B.</p></caption><graphic xlink:href="pharmaceuticals-10-00084-g002"/></fig><fig id="pharmaceuticals-10-00084-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Enantiomeric separation in the essential oil <italic>Niphogeton dissecta</italic>: (<bold>a</bold>) &#x003b2;-pinene; (<bold>b</bold>) sabinene.</p></caption><graphic xlink:href="pharmaceuticals-10-00084-g003"/></fig><fig id="pharmaceuticals-10-00084-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Determination of the IC<sub>50</sub> values for the Acorenone B vs (<bold>a</bold>) acetylcholinesterase (AChE) and (<bold>b</bold>) butyrylcholinesterase (BChE). IC<sub>50</sub>: half maximal inhibitory concentration.</p></caption><graphic xlink:href="pharmaceuticals-10-00084-g004"/></fig><table-wrap id="pharmaceuticals-10-00084-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-10-00084-t001_Table 1</object-id><label>Table 1</label><caption><p>Chemical composition of <italic>Niphogeton dissecta</italic> essential oil of province of Loja, Ecuador.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Component</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LRI <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LRI lit <sup>b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% <sup>c</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x003b4;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Literature for LRI</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">930</td><td align="center" valign="middle" rowspan="1" colspan="1">932</td><td align="center" valign="middle" rowspan="1" colspan="1">3.94</td><td align="center" valign="middle" rowspan="1" colspan="1">1.79</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sabinene</td><td align="center" valign="middle" rowspan="1" colspan="1">969</td><td align="center" valign="middle" rowspan="1" colspan="1">969</td><td align="center" valign="middle" rowspan="1" colspan="1">1.41</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">974</td><td align="center" valign="middle" rowspan="1" colspan="1">974</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Myrcene</td><td align="center" valign="middle" rowspan="1" colspan="1">987</td><td align="center" valign="middle" rowspan="1" colspan="1">988</td><td align="center" valign="middle" rowspan="1" colspan="1">2.14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">p-Cymene</td><td align="center" valign="middle" rowspan="1" colspan="1">1022</td><td align="center" valign="middle" rowspan="1" colspan="1">1020</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">1027</td><td align="center" valign="middle" rowspan="1" colspan="1">1024</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(Z)-&#x003b2;-Ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">1034</td><td align="center" valign="middle" rowspan="1" colspan="1">1032</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E)-&#x003b2;-Ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">1045</td><td align="center" valign="middle" rowspan="1" colspan="1">1044</td><td align="center" valign="middle" rowspan="1" colspan="1">29.64</td><td align="center" valign="middle" rowspan="1" colspan="1">1.63</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b3;-Terpinolene</td><td align="center" valign="middle" rowspan="1" colspan="1">1055</td><td align="center" valign="middle" rowspan="1" colspan="1">1056</td><td align="center" valign="middle" rowspan="1" colspan="1">0.29</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B19-pharmaceuticals-10-00084" ref-type="bibr">19</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1072</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Pinene oxide</td><td align="center" valign="middle" rowspan="1" colspan="1">1093</td><td align="center" valign="middle" rowspan="1" colspan="1">1099</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1155</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E,E) 2,6-Dimethyl-3,5,7-octatriene-2-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">1205</td><td align="center" valign="middle" rowspan="1" colspan="1">1207</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B20-pharmaceuticals-10-00084" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Citronellol</td><td align="center" valign="middle" rowspan="1" colspan="1">1224</td><td align="center" valign="middle" rowspan="1" colspan="1">1223</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1256</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Geranial</td><td align="center" valign="middle" rowspan="1" colspan="1">1264</td><td align="center" valign="middle" rowspan="1" colspan="1">1264</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Methyl geranate</td><td align="center" valign="middle" rowspan="1" colspan="1">1318</td><td align="center" valign="middle" rowspan="1" colspan="1">1322</td><td align="center" valign="middle" rowspan="1" colspan="1">0.51</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1334</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Copaene</td><td align="center" valign="middle" rowspan="1" colspan="1">1371</td><td align="center" valign="middle" rowspan="1" colspan="1">1374</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Funebrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1411</td><td align="center" valign="middle" rowspan="1" colspan="1">1413</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E)-Caryophyllene</td><td align="center" valign="middle" rowspan="1" colspan="1">1414</td><td align="center" valign="middle" rowspan="1" colspan="1">1417</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Cedrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1417</td><td align="center" valign="middle" rowspan="1" colspan="1">1419</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">cis-Thujopsene</td><td align="center" valign="middle" rowspan="1" colspan="1">1420</td><td align="center" valign="middle" rowspan="1" colspan="1">1429</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E)-&#x003b2;-Farnesene</td><td align="center" valign="middle" rowspan="1" colspan="1">1450</td><td align="center" valign="middle" rowspan="1" colspan="1">1454</td><td align="center" valign="middle" rowspan="1" colspan="1">1.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">allo-aromadendrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1454</td><td align="center" valign="middle" rowspan="1" colspan="1">1458</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Himachalene</td><td align="center" valign="middle" rowspan="1" colspan="1">1457</td><td align="center" valign="middle" rowspan="1" colspan="1">1449</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">cis-Cadina-1(6),4-diene</td><td align="center" valign="middle" rowspan="1" colspan="1">1466</td><td align="center" valign="middle" rowspan="1" colspan="1">1461</td><td align="center" valign="middle" rowspan="1" colspan="1">1.70</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b3;-Muurolene</td><td align="center" valign="middle" rowspan="1" colspan="1">1469</td><td align="center" valign="middle" rowspan="1" colspan="1">1478</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Germacrene-D</td><td align="center" valign="middle" rowspan="1" colspan="1">1475</td><td align="center" valign="middle" rowspan="1" colspan="1">1484</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ar-Curcumene</td><td align="center" valign="middle" rowspan="1" colspan="1">1477</td><td align="center" valign="middle" rowspan="1" colspan="1">1479</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Zingiberene</td><td align="center" valign="middle" rowspan="1" colspan="1">1491</td><td align="center" valign="middle" rowspan="1" colspan="1">1493</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E,E)-&#x003b1;-Farnesene</td><td align="center" valign="middle" rowspan="1" colspan="1">1501</td><td align="center" valign="middle" rowspan="1" colspan="1">1505</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1506</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b4;-Cadinene</td><td align="center" valign="middle" rowspan="1" colspan="1">1513</td><td align="center" valign="middle" rowspan="1" colspan="1">1522</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Sesquiphellandrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1519</td><td align="center" valign="middle" rowspan="1" colspan="1">1521</td><td align="center" valign="middle" rowspan="1" colspan="1">0.89</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E)-Nerolidol</td><td align="center" valign="middle" rowspan="1" colspan="1">1557</td><td align="center" valign="middle" rowspan="1" colspan="1">1561</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1565</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Spathulenol</td><td align="center" valign="middle" rowspan="1" colspan="1">1569</td><td align="center" valign="middle" rowspan="1" colspan="1">1577</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1581</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1585</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Geranyl isovalerate</td><td align="center" valign="middle" rowspan="1" colspan="1">1594</td><td align="center" valign="middle" rowspan="1" colspan="1">1606</td><td align="center" valign="middle" rowspan="1" colspan="1">0.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cedrol</td><td align="center" valign="middle" rowspan="1" colspan="1">1600</td><td align="center" valign="middle" rowspan="1" colspan="1">1600</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1609</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Cadinol</td><td align="center" valign="middle" rowspan="1" colspan="1">1645</td><td align="center" valign="middle" rowspan="1" colspan="1">1652</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1655</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Acorenone</td><td align="center" valign="middle" rowspan="1" colspan="1">1666</td><td align="center" valign="middle" rowspan="1" colspan="1">1655</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-pharmaceuticals-10-00084" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Acorenone B</td><td align="center" valign="middle" rowspan="1" colspan="1">1683</td><td align="center" valign="middle" rowspan="1" colspan="1">1675</td><td align="center" valign="middle" rowspan="1" colspan="1">41.01</td><td align="center" valign="middle" rowspan="1" colspan="1">3.35</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B22-pharmaceuticals-10-00084" ref-type="bibr">22</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(3E)-Butylidene phthalide</td><td align="center" valign="middle" rowspan="1" colspan="1">1718</td><td align="center" valign="middle" rowspan="1" colspan="1">1717</td><td align="center" valign="middle" rowspan="1" colspan="1">5.54</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">1777</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sandaracopimaradiene</td><td align="center" valign="middle" rowspan="1" colspan="1">1943</td><td align="center" valign="middle" rowspan="1" colspan="1">1942</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B23-pharmaceuticals-10-00084" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Biformene</td><td align="center" valign="middle" rowspan="1" colspan="1">1983</td><td align="center" valign="middle" rowspan="1" colspan="1">1990</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">2008</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(E,E)-Geranyl linalool</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">2026</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-pharmaceuticals-10-00084" ref-type="bibr">18</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">2047</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">trace</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unidentified</td><td align="center" valign="middle" rowspan="1" colspan="1">2052</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">--</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Monoterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">37.97</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oxygenated monoterpene</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sesquiterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">9.71</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oxygenated sesquiterpene</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">42.31</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Others</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">6.22</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total amount of compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.46%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>a</sup></bold> Calculated linear retention indices (LRI) on DB-5MS capillary column; <bold><sup>b</sup></bold> Linear retention indices according to literature; <bold><sup>c</sup></bold> Relative percentage values are means of four determinations with a Relative Standard Deviation (RSD%) below 5% for the most abundant components. Traces % &#x0003c; 0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-10-00084-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-10-00084-t002_Table 2</object-id><label>Table 2</label><caption><p>Enantiomeric excess of some essential oil constituents from <italic>Niphogeton dissecta</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Components</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT <sup>a</sup> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LRI <sup>b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Enantiomeric Distribution (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>e.e.</italic> (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">(+)-&#x003b2;-pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">11.08</td><td align="center" valign="middle" rowspan="1" colspan="1">957</td><td align="center" valign="middle" rowspan="1" colspan="1">86.9</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">73.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-&#x003b2;-pinene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">965</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(+)-Sabinene</td><td align="center" valign="middle" rowspan="1" colspan="1">12.47</td><td align="center" valign="middle" rowspan="1" colspan="1">983</td><td align="center" valign="middle" rowspan="1" colspan="1">80.9</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">61.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&#x02212;)-Sabinene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">997</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.1</td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>a</sup></bold> Retention Time (RT); <bold><sup>b</sup></bold> Calculated on MEGA-DEX-DET chiral stationary phase.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-10-00084-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-10-00084-t003_Table 3</object-id><label>Table 3</label><caption><p>Strains used for biological tests.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Microorganism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">E.O, (<italic>Niphogeton dissecta</italic>) mg/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Acorenone B (mg/mL)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Candida albicans</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Enterococcus faecalis</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Escherichia coli</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Micrococcus luteus</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>NA = non-active.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-10-00084-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-10-00084-t004_Table 4</object-id><label>Table 4</label><caption><p>Cholinesterase inhibitory activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AChE (IC<sub>50</sub>) &#x003bc;g/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BChE (IC<sub>50</sub>) &#x003bc;g/mL</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Niphogeton dissecta</italic> essential oil</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">11.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acorenone B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.9</td></tr></tbody></table><table-wrap-foot><fn><p>NA = non-active.</p></fn></table-wrap-foot></table-wrap></floats-group></article>